0000902664-16-008843.txt : 20161116 0000902664-16-008843.hdr.sgml : 20161116 20161116170952 ACCESSION NUMBER: 0000902664-16-008843 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161114 FILED AS OF DATE: 20161116 DATE AS OF CHANGE: 20161116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS Corp CENTRAL INDEX KEY: 0001361248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 1305 CITY: PAOLI STATE: NY ZIP: 19301 BUSINESS PHONE: 610-889-9900 MAIL ADDRESS: STREET 1: P.O. BOX 1305 CITY: PAOLI STATE: NY ZIP: 19301 FORMER COMPANY: FORMER CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20060501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIGHBRIDGE CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0000919185 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36208 FILM NUMBER: 162003102 BUSINESS ADDRESS: STREET 1: 40 WEST 57TH ST. STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2122874900 MAIL ADDRESS: STREET 1: 40 WEST 57TH ST. STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: HIGHBRIDGE CAPITAL MANAGEMENT INC /NY DATE OF NAME CHANGE: 19980610 FORMER NAME: FORMER CONFORMED NAME: DUBIN & SWIECA ASSET MANAGEMENT INC DATE OF NAME CHANGE: 19950817 4 1 p16-2179form4.xml TETRALOGIC PHARMACEUTICALS CORPORATION X0306 4 2016-11-14 1 0001361248 TETRALOGIC PHARMACEUTICALS Corp TLOG 0000919185 HIGHBRIDGE CAPITAL MANAGEMENT LLC 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 0 0 0 1 See Remarks The Reporting Person is filing this Form 4 to exit the Section 16 reporting system because on November 14, 2016, the Reporting Person waived its right to convert any of the principal amount of the 8% Senior Convertible Notes due 2019 (the "Senior Notes") into shares of the Issuer's common stock, par value $0.0001 per share unless and until the date upon which the Issuer receives a milestone or earn-out payment pursuant to Section 3.2 or Section 3.3 of the APA (as defined in the Reporting Person's Form 3 filed on November 14, 2016) (or other payment in lieu thereof). The Reporting Person expressly disclaims having been a member in a "group", within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended, with the other holders of the Senior Notes (the "Other Noteholders") or any other person. In addition, the Reporting Person disclaims beneficial ownership of any shares of Common Stock beneficially owned by the Other Noteholders. However, if the Reporting Person was found to have been a member of a group with the Other Noteholders by virtue of the events described in the Schedule 13D filed by the Reporting Person on November 14, 2016, then, based on information and belief, such group would have beneficially owned in excess of 10% of the Issuer's Common Stock prior to the conversion waiver described above. /s/ Highbridge Capital Management, LLC; By: John Oliva, its Managing Director 2016-11-16